Clinical Trial Update: Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases?

View source ↗

Summary

This document provides a clinical trial update on using interferon-lambda as a potential biologic approach to neutrophil-mediated pathology in rheumatic disease…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Vasculitis

Drugs mentioned

• Interferon-lambda (Interferon lambda)

Snippet

Sponsor: University of Oxford | Conditions: Arthritis, Vasculitis | Status: UNKNOWN